Clinical Trials Logo

Trigeminal Neuralgia clinical trials

View clinical trials related to Trigeminal Neuralgia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05914558 Active, not recruiting - Clinical trials for Temporomandibular Disorder

Comorbid Painful TMD Among Trigeminal Neuralgia

TNTMD
Start date: August 1, 2022
Phase:
Study type: Observational

An observational study following up with trigeminal neuralgia patients to understand their comorbid facial pain condition, specifically temporomandibular disorder.

NCT ID: NCT05147454 Active, not recruiting - Facial Pain Clinical Trials

MRI & QST Analysis in Trigeminal Neuralgia and Persistent Idiopathic Facial Pain

Start date: November 11, 2021
Phase:
Study type: Observational

Patients with a definite diagnosis of classical TGN and PIFP will undergo a structured clinical questionnaire and a trigeminal sensory profile using the quantitative sensory testing. Clinical measures and sensory profiles will be correlated with MRI measures.

NCT ID: NCT04174443 Active, not recruiting - Clinical trials for Trigeminal Neuralgia

The Efficacy and Safety of Pulsed Radiofrequency Combined With Continuous Radiofrequency for the Trigeminal Neuralgia

PRFCRF
Start date: December 2, 2020
Phase: N/A
Study type: Interventional

Trigeminal neuralgia is a very painful condition, and radiofrequency therapy is reserved for patients who are resistant or intolerant to pharmacological therapy. Continuous radiofrequency and pulsed radiofrequency both have advantages and disadvantages. Recently, studies have found that pulsed radiofrequency combined with low-temperature (<65 °C) continuous radiofrequency increases the efficacy of the treatment, without leading to a significant increase in complications caused by nerve lesions. However, these reports have some limitations. The investigators plan to conduct a randomized, controlled study to compare the efficacy of applying high-voltage pulsed radiofrequency, with and without low-temperature continuous radiofrequency, to the gasserian ganglion for the treatment of trigeminal neuralgia. The primary outcome will be the effectiveness of the treatment after 12 months which is the percentage of participants with a modified Barrow Neurological Institute Pain Intensity Score between I-III.

NCT ID: NCT03152955 Active, not recruiting - Clinical trials for Trigeminal Neuralgia

Postoperative Analgesia in Patients With Microvascular Decompression

Start date: May 15, 2017
Phase: Phase 4
Study type: Interventional

Perioperative pain is caused by a variety of harmful factors through multiple mechanisms, therefore, reasonable postoperative analgesia should be combined with drugs or measures of different mechanism , which is called multimodal analgesia. Multimodal analgesia could minimize side effects and achieve a better analgesic effect. Commonly used strategies of multimodal analgesia are oral analgesic drug, nerve block, patient controlled analgesia and so on. This study will observe the effect of multimodal analgesia on postoperative pain in patients with microvascular decompression and record side effects. Finally, it will provide technical support for the guidance of postoperative analgesia in patients of trigeminal neuralgia.

NCT ID: NCT02708810 Active, not recruiting - Clinical trials for Trigeminal Neuralgia

RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery

Start date: November 2015
Phase: N/A
Study type: Interventional

To determine the feasibility of frameless Virtual Cone trigeminal neuralgia radiosurgery at a single institution prior to multi-institutional enrollment.